ANVISA-2020-0065-V065

Major variation for application ANVISA-2020-0065. Major variation: Formulation Change for Immunovant-α — routine update

Variation Number
ANVISA-2020-0065-V065
Type
Major
Application
ANVISA-2020-0065
Change
CHG-2024-0065
Status
Blocked
Fee
€21,122
Submitted
2023-04-22
Approved
—
Description

Major variation: Formulation Change for Immunovant-α — routine update